News - Servier

Filter

Current filters:

Servier

Popular Filters

1 to 25 of 43 results

European Generic Medicines Association speaks out against EC’s perindopril decision

European Generic Medicines Association speaks out against EC’s perindopril decision

09-07-2014

The European Generic Medicines Association (EGA) has expressed concerns over the European Commission’s…

Cardio-vascularEuropeGenericsLegalLupinperindoprilServierunichem

Ivabradine and CV events in angina patients under review in Australia

Ivabradine and CV events in angina patients under review in Australia

23-06-2014

Australian pharma regulator the Therapeutic Goods Administration (TGA) is reviewing new information regarding…

AustraliaCardio-vascularCoralanivabradinePharmaceuticalRegulationServier

Servier inks oncology collaboration with Novartis

20-05-2014

French independent drugmaker Laboratories Servier has signed a strategic global collaboration agreement…

LicensingNovartisOncologyPharmaceuticalServier

Jacques Servier, founder and president of Lab Servier, dies aged 92

17-04-2014

French independent drugmaker Laboratories Servier announced that its founder and president, Jacques Servier,…

BoardroomManagementPharmaceuticalServier

Celladon signs option agreement with Servier

24-02-2014

USA-based biotech firm Celladon has entered into an option agreement with French independent drugmaker…

BiotechnologyCelladonDiabetesLicensingServier

Servier and Cellectis collaborate on leukemia and solid tumors candidates

Servier and Cellectis collaborate on leukemia and solid tumors candidates

18-02-2014

Allogeneic CAR T-cell therapies specialist Cellectis has signed a strategic collaboration agreement with…

CellectisLicensingOncologyPharmaceuticalResearchServierUCART19

Servier Canada collaborates in two research projects

Servier Canada collaborates in two research projects

17-02-2014

Two major projects in clinical research conducted by Canada’s Montreal Heart Institute (MHI) and the…

CanadaCardio-vascularFinancialNorth AmericaPharmaceuticalResearchServier

$20 million milestones for MacroGenics from Servier

$20 million milestones for MacroGenics from Servier

06-02-2014

Servier, France’s largest privately‐held pharmaceutical company, has exercised its exclusive option…

FinancialHematologyLicensingMacroGenicsMGD006OncologyPharmaceuticalServier

Curie-Cancer and Servier renew partnership into ‘triple negative’ breast cancers

Curie-Cancer and Servier renew partnership into ‘triple negative’ breast cancers

28-01-2014

French privately-held drugmaker Servier has renewed its partnership with Curie-Cancer to identify therapeutic…

FranceOncologyPharmaceuticalResearchServier

Hybrigenics achieves research milestone under Servier collaboration

Hybrigenics achieves research milestone under Servier collaboration

21-01-2014

French drug developer Hybrigenics says it has achieved first drug discovery milestone in connection with…

FinancialHybrigenicsOncologyPharmaceuticalResearchServier

EMA pharmacovigilance unit calls for suspension of Protelos/Osseor

EMA pharmacovigilance unit calls for suspension of Protelos/Osseor

10-01-2014

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has recommended…

Anti-Arthritics/RheumaticsEuropeOsseorPharmaceuticalProtelosRegulationServierWomen's Health

Clovis Oncology buys Italian firm for $200 million

21-11-2013

US biotech firm Clovis Oncology says it has acquired EOS (Ethical Oncology Science), a privately-held…

BiotechnologyClovis OncologylucitanibMergers & AcquisitionsOncologyServier

Xention and Servier sign up for cardiovascular collaboration

Xention and Servier sign up for cardiovascular collaboration

02-10-2013

Xention and Servier have entered into a multi-year agreement for the development and commercialization…

BiotechnologyCardio-vascularLicensingServierXention

France’s Servier offers to take full control of Egis Pharma

France’s Servier offers to take full control of Egis Pharma

25-09-2013

French privately-held drugmaker Servier has made a voluntary public offer to buy all outstanding shares…

EGIS PharmaceuticalsEuropeMergers & AcquisitionsPharmaceuticalServier

Amgen's US deal with Servier cleared

13-08-2013

USA-based Amgen (Nasdaq: AMGN), the world's leading independent biotech firm, and privately-held French…

AmgenBiotechnologyCardio-vascularLicensingNorth AmericaPharmaceuticalProcoralanServier

Nerviano collaborates with leading French independent on anti-cancer drug development

01-08-2013

Nerviano Medical Sciences, the largest pharmaceutical R&D facility in Italy, and leading French independent…

LicensingOncologyPharmaceuticalResearchServier

Galapagos and Servier celebrate late stage discovery milestone

24-07-2013

Belgium-based Galapagos (Euronext: GLPG) has announced a late stage discovery milestone for small molecules…

Anti-Arthritics/RheumaticsBiotechnologyEuropeFinancialGalapagosPharmaceuticalServier

Amgen gains rights to Servier's heart drugs ivabradine and S38844

10-07-2013

USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech firm, has entered a new collaboration…

AmgenBiotechnologyCardio-vascularEuropeivabradineLicensingNorth Americaomecamtiv mecarbilPharmaceuticalS38844Servier

XOMA transfers perindopril franchise rights to Symplmed

08-07-2013

California, USA-based XOMA Corp (Nasdaq: XOMA) says it has transferred US development and commercialization…

Cardio-vascularLicensingMergers & AcquisitionsperindoprilPharmaceuticalServierSymplmedXOMA Corp

XOMA's partner Servier launches proof-of-concept clinical program for gevokizumab

25-06-2013

US drug developer XOMA Corp (Nasdaq: XOMA) says that its development partner, French independent drugmaker…

Anti-Arthritics/RheumaticsgevokizumabInflammatory diseasesPharmaceuticalResearchServierXOMA Corp

Afraxis and Servier collaborate on CNS disorder drug discovery

30-04-2013

Privately-held US firm Afraxis and the Institut de Recherches Servier, a part of independent French drugmaker…

AfraxisLicensingNeurologicalPharmaceuticalResearchServier

EMA Committee calls for curbs on Protelos/Osseor, tetrazepam suspension

12-04-2013

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has recommended restrictions…

BayerDiane-35EuropeOsseorPharmaceuticalProtelosRegulationServiertetrazepam

European Commission enforcement action in pharmaceutical sector following sector inquiry

31-01-2013

Following its competition inquiry into the pharmaceutical sector of 2008/2009, the European Commission…

DuragesicEuropeGenericsJohnson & JohnsonLundbeckMarkets & MarketingPatentsPharmaceuticalServier

Four new safety referrals evaluated as impact of new pharmacovigilance legislation kicks in, says EMA

02-12-2012

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) held its fifth meeting…

diacerinEuropeGenericsPharmaceuticalRegulationServierVectarian

1 to 25 of 43 results

Back to top